IL269123A - שיטות לטיפול בסרטן - Google Patents

שיטות לטיפול בסרטן

Info

Publication number
IL269123A
IL269123A IL26912319A IL26912319A IL269123A IL 269123 A IL269123 A IL 269123A IL 26912319 A IL26912319 A IL 26912319A IL 26912319 A IL26912319 A IL 26912319A IL 269123 A IL269123 A IL 269123A
Authority
IL
Israel
Prior art keywords
methods
treating cancer
cancer
treating
Prior art date
Application number
IL26912319A
Other languages
English (en)
Original Assignee
Intercept Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercept Pharmaceuticals Inc filed Critical Intercept Pharmaceuticals Inc
Publication of IL269123A publication Critical patent/IL269123A/he

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542Carboxylic acids, e.g. a fatty acid or an amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL26912319A 2017-03-07 2019-09-04 שיטות לטיפול בסרטן IL269123A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762468259P 2017-03-07 2017-03-07
PCT/US2017/052663 WO2018164715A1 (en) 2017-03-07 2017-09-21 Methods of treating cancer

Publications (1)

Publication Number Publication Date
IL269123A true IL269123A (he) 2019-11-28

Family

ID=63447943

Family Applications (1)

Application Number Title Priority Date Filing Date
IL26912319A IL269123A (he) 2017-03-07 2019-09-04 שיטות לטיפול בסרטן

Country Status (9)

Country Link
EP (1) EP3592357A4 (he)
JP (1) JP7042836B2 (he)
KR (1) KR20190122251A (he)
CN (1) CN110430882A (he)
AU (1) AU2017402623A1 (he)
CA (1) CA3055308A1 (he)
IL (1) IL269123A (he)
TW (1) TW201832768A (he)
WO (1) WO2018164715A1 (he)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4402264A2 (en) * 2021-09-16 2024-07-24 Agency for Science, Technology and Research Modulation of tjp1 expression to treat liver diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003225903A1 (en) * 2002-03-21 2003-10-08 Curagen Corporation Methods of using farnesoid x receptor (fxr) agonists
ES2523591T3 (es) 2006-06-27 2014-11-27 Intercept Pharmaceuticals Inc. Derivados de ácidos biliares como ligandos de FXR para la prevención o el tratamiento de enfermedades o estados mediados por FXR
WO2013037482A1 (en) 2011-09-15 2013-03-21 Phenex Pharmaceuticals Ag Farnesoid x receptor agonists for cancer treatment and prevention
CN104853758A (zh) 2012-11-28 2015-08-19 英特赛普特医药品公司 肺部疾病的治疗
WO2015183794A1 (en) * 2014-05-27 2015-12-03 City Of Hope Tgr5 agonist complexes for treating diabetes and cancer
WO2016086115A1 (en) * 2014-11-26 2016-06-02 Enanta Pharmaceuticals, Inc. Tetrazole derivatives of bile acids as fxr/tgr5 agonists and methods of use thereof
PE20180690A1 (es) * 2015-04-27 2018-04-23 Intercept Pharmaceuticals Inc Composiciones de acido obeticolico y metodos de uso
EP3442946A4 (en) 2016-04-13 2019-12-04 Intercept Pharmaceuticals, Inc. METHOD FOR THE TREATMENT OF CANCER

Also Published As

Publication number Publication date
JP7042836B2 (ja) 2022-03-28
EP3592357A4 (en) 2021-01-13
EP3592357A1 (en) 2020-01-15
AU2017402623A1 (en) 2019-09-26
JP2020510009A (ja) 2020-04-02
CA3055308A1 (en) 2018-09-13
KR20190122251A (ko) 2019-10-29
TW201832768A (zh) 2018-09-16
WO2018164715A1 (en) 2018-09-13
CN110430882A (zh) 2019-11-08

Similar Documents

Publication Publication Date Title
IL275663A (he) שיטות לטיפול בסרטן
IL269026A (he) שיטות לטיפול בגידול
HK1258098A1 (zh) 治療癌症的方法
HK1251408A1 (zh) 治療癌症的方法
ZA201804227B (en) Methods of treating cancer
IL262342A (he) שיטות טיפול בסרטן
EP3606531A4 (en) CANCER TREATMENT METHODS
IL264443A (he) שיטות לטיפול בסרטן הערמונית
ZA201808258B (en) Methods of treating pancreatic cancer
ZA201908539B (en) Method of treatment of cancer
SG11202010793UA (en) Methods of treating cancer
IL263835A (he) טיפול מונחה–אקזוסום בסרטן
EP3487999A4 (en) METHODS OF TREATING CANCER
IL277981A (he) שיטות לטיפול בסרטן
SG11202005163PA (en) Methods of treating cancer
IL281600A (he) שיטות לטיפול בסרטן
GB201717945D0 (en) Method for treatment of cancer
IL269123A (he) שיטות לטיפול בסרטן
IL274748A (he) טיפול משופר בסרטן
IL272379A (he) שיטות לטיפול בסרטן באמצעות עיכוב setds
EP3442555A4 (en) METHODS OF TREATING BREAST CANCER
EP3389670A4 (en) METHODS OF TREATING BREAST CANCER
GB201702139D0 (en) Methods of cancer treatment
GB201704287D0 (en) Treatment of cancer
GB201703857D0 (en) Treatment of cancer